Explore evidence

8.1 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against RBD was 8.1% among females.

MaliSARS-CoV-2 RBDHAL · Unilimdocument of 67 observations

10.7 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 10.7% showed a 10-fold increase in anti-CSP IgG antibody titres post-2019 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2019HAL · Unilimdocument of 105 observations

1.9 per_1000SMC was associated with a 1.9‰ reduction in malaria incidence in health districts with an adjusted coverage rate from 50.0% to 80.0%.

MalipaludismeHAL · Unilimdocument of 111 observations

24 %The clumping phenotype was observed in 24% of severe malaria isolates from Malian children.

Malipaludismepublished 2007The American journal of tropical medicine and hygieneeurope_pmcdocument of 3 observationsDOI 10.4269/ajtmh.2007.77.943

2.69 log10_copies/mLAmong high CMV virus shedders (>1000 copies/mL at day 0), the median viral load at day 14 was 2.69 log10 copies/mL in malaria cases treated with artemether-lumefantrine versus 3.08 log10 copies/mL in non-malaria comparisons.

Malicytomegalovirus (CMV)published 2016Journal of clinical virology : the official publication of the Pan American Society for Cleurope_pmcdocument of 6 observations

91.8 %The median annual seasonal malaria chemoprevention (SMC) coverage rate increased from 91.8% in 2017–2018 to 95.0% in 2021–2022.

Malipaludismeobserved 2017–2018HAL · Unilimdocument of 111 observations

78.21 %The prevalence of normal haemoglobin (HbAA) among 3648 newborns in Mali was 78.21% (95% CI: 76.87–79.55).

Malinormal hemoglobinobserved April–August 2021HAL · Unilimdocument of 103 observations

53.5 msPour le variant rs1137617, la variation de l'intervalle QTc était de 53,5 ms (IC à 95 % : 2,5–93,5 ms) contre 13 ms (IC à 95 % : 8–27 ms) chez les témoins, mais cette différence n'était pas statistiquement significative (P = 0,11).

Malirs1137617HAL · Unilimdocument of 62 observations

400 childrenThe malaria vaccine candidate FMP2.1/AS02A was tested in a Phase 2 clinical trial in 400 Malian children randomized to 3 doses of the AMA1 vaccine candidate or control rabies vaccine on days 0, 30 and 60.

Malipaludismepublished 2016Vaccineeurope_pmcdocument of 2 observations

200 pf/microlThe cut-off value for pyrogenic threshold of Plasmodium falciparum parasitaemia was around 200 pf/microl during the dry season in Bandiagara district, Mali.

Malipaludismeobserved dry season of 1994published 2005Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observationsDOI 10.1111/j.1365-3156.2005.01418.x

78 %L'extrait aqueux de racine de Cassia sieberiana a inhibé les crampes abdominales à hauteur de 78 % dans un test de torsion induite par l'acide acétique chez la souris à la dose de 300 mg/mL.

Malicrampes abdominalesHAL · Unilimdocument of 20 observations

Pre-treatment of red blood cells with neuraminidase, trypsin, and chymotrypsin caused a significant reduction in Plasmodium malariae invasion.

Malipaludismepublished 2025PLoS neglected tropical diseaseseurope_pmcdocument of 4 observations

10 health districtsIn 2021–2022, 10 health districts in the north and south of Mali did not receive seasonal malaria chemoprevention due to COVID-19-related shortages and insufficient resource mobilization by the Malian government.

Malipaludismeobserved 2021–2022HAL · Unilimdocument of 111 observations

5,400 parasites/μLLa parasitémie moyenne pour les infections à Plasmodium ovale chez les participants asymptomatiques était de 5 400 parasites/μL.

MalipaludismeHAL · Unilimdocument of 214 observations

96.1 %The diagnostic performance of SickleScan® for possible sickle cell disease (SCD) in Mali from April to August 2021 showed a sensitivity of 96.10% [95% CI: 94.75–97.45].

Malipossible sickle cell disease (SCD)observed April–August 2021HAL · Unilimdocument of 103 observations

6,311 casesFrom May 2024 to February 2025, 6,311 malaria cases were confirmed in the Kidal region.

Malipaludismeobserved May 2024 to February 2025HAL · Unilimdocument of 80 observations

39 %A significant proportion of participants believed that COVID-19 was a divine punishment (39%).

MaliCOVID-19HAL · Unilimdocument of 88 observations

6.8 %6.8% of individuals in the PIP profile strongly agreed that COVID-19 was a divine punishment.

MaliCOVID-19HAL · Unilimdocument of 88 observations

1 %Allele frequencies of K13-propeller mutations in sub-Saharan Africa ranged between 1% and 3%.

Malipaludismepublished 2015The Journal of infectious diseaseseurope_pmcdocument of 4 observations

60 %En 2018, seulement 60 % des cas de paludisme avaient été confirmés par microscopie optique au Mali.

Malipaludismeobserved 2018HAL · Unilimdocument of 214 observations

74.5 %After 3 years of seasonal malaria chemoprevention (SMC), the frequency of Pfdhps 437G mutation in Plasmodium falciparum was 74.5% compared to 64.6% at baseline in Ouelessebougou, Mali.

Malipaludismeobserved 2014-2016published 2022Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/s12936-022-04059-z

1,380 parasites/microlitreLa médiane du nombre de parasites de Plasmodium ovale par microlitre chez les 95 patients du groupe Kollé est de 1 380 (IQR : 1 020–1 740).

MalipaludismeHAL · Unilimdocument of 62 observations

65.2 %Le taux de prévalence du paludisme chez les personnes malades était de 65,2 % dans la localité étudiée.

MalipaludismeHAL · Unilimdocument of 214 observations

84 %About 84% of the population lived in high and moderate malaria transmission strata.

MalipaludismeHAL · Unilimdocument of 95 observations

30 daysPatients with stronger responses to S, RBD, or RBM experienced remission in a shorter time period (≤30 days).

MaliCOVID-19HAL · Unilimdocument of 67 observations